MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Budrul Chukrut | Lightrocket | Getty Images Vaccine maker Novavax on Wednesday reported fourth-quarter revenue and earnings that missed Wall Street’s estimates and reiterated plans to cut costs as it fights to stay afloat. Still, Novavax narrowed its losses in the quarter from the same period … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Thursday posted a surprise quarterly profit, in part boosted by deferred revenue, even as the company saw slumping sales from its Covid vaccine, its only marketable product. The results cap a rocky year for the biotech company and … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It’s been hard to keep up. That’s the story of the big stock winners this year. They just keep winning and winning and winning. For analysts on Wall Street and here at the Club, it seems like some of these names are smashing through our six-to-nine-month … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A UnitedHealth Group health insurance card is seen in a wallet, Oct.14, 2019. Lucy Nicholson | Reuters Good afternoon! Health insurers are feeling the squeeze as older patients head to the doctor more than expected. CVS, which owns health insurer Aetna, on Wednesday slashed its full-year profit outlook, … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen on Tuesday reported fourth-quarter revenue and profit that shrank from a year ago, as it recorded charges related to dropping its controversial Alzheimer’s drug Aduhelm and as sales slumped in its multiple sclerosis therapies, the company’s … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. U.S. stocks were modestly higher Monday as the market awaits key economic data. Traders will be mulling over the consumer … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. 1. U.S. stocks were mostly higher on Friday. The S & P 500 was on track for a fifth positive week … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A CVS location in New York, US, on Thursday, Feb. 9, 2023. Stephanie Keith | Bloomberg | Getty Images CVS Health on Wednesday reported fourth-quarter revenue and adjusted earnings that topped expectations, but the company cut its full-year profit outlook, citing higher medical costs that are … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Business at GE Healthcare Technologies capped off 2023 on a strong note despite ongoing concerns about China. That coupled with management’s upbeat view of this year propelled shares up more than 13% to over $83 each at session highs. That was their highest level since July … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. U.S. stocks were mixed Tuesday, on a muted performance from Big Tech. Citigroup strategists warned that tech stocks may stall … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020. Mike Blake | Reuters Eli Lilly on Tuesday reported fourth-quarter revenue and adjusted earnings that topped expectations on the strong launch of its new weight loss drug, Zepbound, … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., February 1, 2024. Brendan McDermid | Reuters Here’s how big of a surprise corporate profits have been this earnings season: the fourth-quarter is now shaping up to be the … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Bristol Myers Squibb reported quarterly earnings and revenue that topped expectations on Friday as its portfolio of new drugs posted strong sales growth. Here’s what the company reported for the fourth quarter compared with what Wall Street was expecting, based on a survey of analysts by … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The logo for Merck & Co. is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, New York, U.S., November 17, 2021. Andrew Kelly | Reuters Merck on Thursday reported fourth-quarter revenue and adjusted earnings that topped estimates as it … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We’re selling 95 shares of GE Healthcare at roughly $74. Following Wednesday’s trade, Jim Cramer’s Charitable Trust will own 1,150 shares of GEHC, reducing its weighting to 2.75% from 2.97%. The small trim we’re making in GE Healthcare with the stock up slightly in an otherwise … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Liselotte Sabroe | Afp | Getty Images Novo Nordisk, Europe’s largest company by market capitalization, on Wednesday reported better-than-expected 2023 earnings, as sales of its wildly popular anti-obesity and diabetes drugs continued to soar. The maker of weight loss drug Wegovy and diabetes drug Ozempic reported … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer CEO Albert Bourla talks during a press conference with European Commission President Ursula von der Leyen after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021. John Thys | … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Signage is displayed on a Humana Inc. office building in Louisville, Kentucky, U.S., on Sunday, Feb. 3, 2019. Humana is scheduled to release earnings figures on February 6. Photographer: Luke Sharrett/Bloomberg via Getty Images Bloomberg | Bloomberg | Getty Images Shares of Humana plummeted on Thursday … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The stock trading graph of Johnson & Johnson is seen on a smartphone screen. Rafael Henrique | SOPA Images | LightRocket | Getty Images Johnson & Johnson on Tuesday reported fourth-quarter earnings and revenue that narrowly edged out Wall Street’s expectations as sales in the company’s pharmaceutical … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A man walks near a Walgreens pharmacy on March 09, 2023 in New York City. Leonardo Munoz | Corbis News | Getty Images Walgreens reported fiscal first-quarter adjusted earnings and revenue that topped expectations on Thursday, but cut its quarterly dividend nearly in half. The retail … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly on Thursday reported third-quarter revenue and adjusted earnings that topped estimates on strong demand for its diabetes drug Mounjaro, but slashed its full-year profit guidance due … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Thursday posted a steep loss for the third quarter as the drugmaker recorded a large write-down due to unused Covid vaccines, its only marketable products. Moderna’s total revenue for the period topped Wall Street’s expectations, even amid … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The post-earnings decline in Humana (HUM) shares Wednesday was overdone, providing investors an opportunity to add to their positions in the Medicare Advantage-focused health insurer. The Club holding remains on solid ground after delivering a top- and bottom-line beat in the third quarter. Revenue for the … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A woman walks past a CVS Pharmacy in Washington, D.C., on Nov. 2, 2022. Brendan Smialowski | AFP | Getty Images CVS on Wednesday reported third-quarter adjusted earnings and revenue that topped Wall Street’s expectations, lifted in part by strong revenue from the company’s health services … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE CFOTO | Future Publishing | Getty Images Pfizer on Tuesday reported a narrower than expected loss for the third quarter as the drugmaker recorded charges largely related to struggles for its Covid antiviral treatment Paxlovid and Covid vaccine. Pfizer said that it recorded a $5.6 billion … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Elevated bond yields and geopolitical uncertainty continued to be negative for stocks this week as the overall market moved into oversold territory. However, that set us up to put cash to work and make four small buys as our discipline mandates. We also upgraded one of … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Bristol Myers Squibb on Thursday reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates, even as sales of the company’s popular blood cancer drug Revlimid plummeted due to generic competition. Bristol Myers, one of the world’s largest pharmaceutical companies, raked in … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Merck headquarters in Rahway, New Jersey, on Tuesday, April 18, 2023. Christopher Occhicone | Bloomberg | Getty Images Merck on Thursday reported third-quarter revenue and adjusted earnings that topped expectations on strong sales of its blockbuster cancer drug Keytruda, HPV vaccine Gardasil and surprisingly, its Covid … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The stock is under pressure in early trading due to uncertainty around the recovery in a key business. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Tuesday reported adjusted earnings and revenue that topped Wall Street’s expectations, driven by a surge in sales … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Here’s our Club Mailbag email investingclubmailbag@cnbc.com — so you send your questions directly to Jim Cramer and his team of analysts. We can’t offer personal investing advice. We will only consider more general questions about the investment process or stocks in the portfolio or related industries. … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer CEO Albert Bourla talks during a press conference with the president of the European Commission after a visit to oversee the production of the Pfizer-BioNTech Covid-19 vaccine at the factory of U.S. pharmaceutical company Pfizer, in Puurs, Belgium, April 23, 2021. John Thys | AFP … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An Ozempic injection pen is seen on a kitchen table in Riga, Latvia, on Aug. 6, 2023. Jaap Arriens | Nurphoto | Getty Images Novo Nordisk on Friday raised its outlook for its full-year sales and operating profit due to soaring demand for its blockbuster weight … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Traders work at the post where UnitedHealth Group is traded on the floor of the New York Stock Exchange. Brendan McDermid | Reuters UnitedHealth Group‘s (UNH) quality quarterly results Friday are a good sign for the broader health-care landscape, CNBC’s Jim Cramer said. The managed-care giant … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It’s encouraging to see three Club stocks on the bullish side of Goldman Sachs’ new list of 25 tactical trades for earnings season. Asset allocation can be strategic or tactical. Strategic asset allocation generally refers to longer-term investing — think of this as your buy-and-hold approach. … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A man walks near a Walgreens pharmacy on March 09, 2023 in New York City. Leonardo Munoz | Corbis News | Getty Images Walgreens on Thursday offered soft profit guidance and reported fiscal fourth-quarter earnings that fell short of expectations, as demand for Covid vaccines and … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It’s taken some patience. But shares of this company finally broke through $500 each in Friday trading, so we’re ringing the register. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We care much more about where a stock is going than where it’s been. With the spin-off of Veralto (VLTO) complete, we decided to look at the path ahead for Danaher (DHR) — now free of its slower-growing, lower-margin water business. In the separation , we … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Our portfolio experienced a flurry of adjustments in a week dominated by Nvidia’s (NVDA) quarterly results Wednesday evening and Federal Reserve Chairman Jerome Powell’s Jackson Hole address Friday. Here’s a day-by-day look at the trades and price-target changes, and what motivated each decision. Monday Monday proved … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Since the CNBC Investing Club’s July Monthly Meeting, the stock market has seesawed up and then down on a slew of quarterly earnings results and inflation data. That’s left Wall Street struggling this month. Here’s a look at the best performers from the Club’s 36 holdings … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The extraordinary activist-investor interest in Salesforce (CRM) eased further in the second quarter, according to the latest regulatory filings from influential Wall Street pros. These big-name investors also made moves in nine other Club stocks during a strong three-month stretch that ended the best first half … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Here’s our Club Mailbag email investingclubmailbag@cnbc.com — so you send your questions directly to Jim Cramer and his team of analysts. We can’t offer personal investing advice. We will only consider more general questions about the investment process or stocks in the portfolio or related industries. … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. U.S. stocks rose Monday, though they’re still having a rough August. Nvidia (NVDA), which has been slumping recently, jumped about … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. Jim Vondruska | Reuters Novo Nordisk, which makes the weight-loss drug Wegovy, raised its outlook for 2023 Thursday, as it reported soaring … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Medical syringes and Novavax logo displayed in the background are seen in this illustration photo taken in Krakow, Poland on December 2, 2021. Jakub Porzycki | NurPhoto | Getty Images Shares of Novavax jumped as much as 20% in premarket trading Tuesday after the Covid vaccine … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sopa Images | Lightrocket | Getty Images Eli Lilly on Tuesday raised its full-year guidance as second-quarter profit jumped 85% from the same period a year ago on strong sales from the pharmaceutical giant’s drug pipeline. The company now expects full-year revenue of between $33.4 billion … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In a jam-packed week of earnings, the Club executed multiple trades and elevated price targets for some of our biggest stocks. Many of these moves stemmed from what we saw in quarterly numbers and heard on conference calls. Here’s a day-by-day look at the portfolio action. … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Troubled Club holding Bausch Health Companies (BHC) reported better-than-expected quarterly results before the bell Thursday. However, it’s not nearly enough to get this stock out of the penalty box. Sales in the second quarter rose 10% to $2.17 billion, exceeding expectations of $2.04 billion, according to … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Artur Widak | Nurphoto | Getty Images Shares of Moderna rose Thursday after the biotech company hiked its full-year outlook for its Covid vaccine, its only marketable product, despite reporting a quarterly loss and sharp drop in revenue. The biotech company generated second-quarter sales of $344 … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A Humana office in Louisville, Kentucky, US, on Monday, July 31, 2023. Jon Cherry | Bloomberg | Getty Images Humana shares rose Wednesday after the health insurer said medical costs came in lower than expected during its second-quarter earnings report. The results ease investor concerns two … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A customer exits a CVS Health Corp. store in Oakland, California, U.S., on Friday, Aug. 2, 2019. Michael Short | Bloomberg | Getty Images CVS Health on Wednesday reported second-quarter earnings and revenue that beat expectations, as the company slashes costs and lays off thousands of … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pavlo Gonchar | Lightrocket | Getty Images Pfizer on Tuesday reported second-quarter adjusted earnings that topped Wall Street’s expectations, but posted revenue that fell short of estimates as Covid product sales plunged. Pfizer reported second-quarter sales of $12.73 billion, down 54% over the same period a … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on October 4, 2021. NurPhoto | NurPhoto | Getty Images Merck on Tuesday reported second-quarter revenue that topped expectations on strong sales of its blockbuster … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We’re taking a hard look at the Bullpen and the rest of the market for new opportunities. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen said on Tuesday that he expected to cut about 1,000 jobsor about 11% of its workforce to save costs as a biotechnology company is gearing up to launch its newly approved Alzheimer’s drug Leqembi. It’s the … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Kenvue, a unit of Johnson & Johnson’s Healthcare. CANJSKA PHOTOGRAPHY | Future Publishing | Getty Images Johnson & Johnson said on Monday that it plans to cut by at least 80% your share at Kenvue, a consumer health company spun out as a standalone company earlier … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Thibaut Mongon, CEO of Kenvue Inc., Johnson & Johnson’s consumer health business, speaks during an interview to celebrate its IPO on the New York Stock Exchange (NYSE), May 4, 2023. Brendan McDermid | Reuters Most consumers have reduced consumption as inflation squeezes their wallets, but they … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Johnson & Johnson ( JNJ ) reported strong second-quarter earnings and revenue ahead of the opening bell on Thursday, with better-than-expected results both domestically and internationally and across all major operating segments. J & J’s sales rose 6.3% year-over-year to $25.53 billion in the second quarter, … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Kenvue, a unit of Johnson & Johnson’s Healthcare. CANJSKA PHOTOGRAPHY | Future Publishing | Getty Images Kenvue reported second-quarter revenue and adjusted earnings beat expectations on Thursday in the consumer health company’s first quarterly report since exiting Johnson & Johnson two months ago. The company also … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In this photo illustration, a stock trading chart of Johnson and Johnson is seen on a smartphone screen. Rafael Henrique | SOPA Images | LightRocket | Getty Images Johnson & Johnson on Thursday reported second-quarter revenue and adjusted earnings that beat Wall Street expectations and lifted … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Novartis announced in August that it plans to spin off its Sandoz generics unit to focus more on its patented prescription drugs. Bloomberg | Bloomberg | Getty Images Novartis shares jumped on Tuesday after the Swiss drugmaker raised its full-year guidance to strong selling drugs and … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Representatives talk to customers at a UnitedHealthcare store in Queens, New York. Michael Nagle | Bloomberg | Getty Images UnitedHealth Group’The stock price jumped on Friday after the healthcare conglomerate’s report second quarter revenue and adjusted earnings which nevertheless exceeded Wall Street expectations rising medical costs. … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. Earnings and Inflation See J & J Upbeat Outlook for Meta 1 Earnings and Inflation US stocks rose on Monday, with … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE People approach a Walgreens pharmacy on March 9, 2023 in New York City. Leonardo Munoz | Corbis News | Getty Images Walgreens cut its full-year profit guidance on Tuesday after missing Wall Street expectations for the fiscal third quarter due to lower consumer spending and a … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A health worker prepares a dose of the Novavax vaccine as the Netherlands Health Organization begins the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Company shares Novavax rose 5% in premarket trading on Tuesday company revealed … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Thibaut Mongon, CEO and Paul Ruh CFO of Kenvue Inc., a Johnson & Johnson consumer health company, pose together during the company’s IPO on the New York Stock Exchange (NYSE) in New York, U.S., May 4, 2023. Brendan McDermid | Reuters Johnson & JohnsonKenvue’s consumer health … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Moderne sign is seen outside their headquarters in Cambridge, MA on March 11, 2021. The Boston Globe | Getty Images Modern beat past estimates for first-quarter earnings and revenue on Thursday and posted a surprise quarterly profit, despite lower demand for its only marketed product … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pharmaceutical Pfizer Inc. said an oral drug to treat COVID-19 could be available by the end of 2021. Soumyabrata Roy | NurPhoto | Getty Images Pfizer on Tuesday reported first-quarter revenue and adjusted earnings that beat Wall Street expectations, despite a drop in sales caused by … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Carl Icahn speaks at Delivering Alpha in New York on September 13, 2016. David A. Grogan | CNBC Carl Icahn called on Friday Illuminina the first quarter the results “very disappointing” and criticized the DNA sequencing company new plans reduce costs. The activist investor, who owns … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In this illustration photo taken in Poland on Oct. 4, 2021, a medical pill is shown with the Merck logo displayed on a screen in the background. NurPhoto | NurPhoto | Getty Images Merck on Thursday reported first-quarter revenue that fell 9% from the same period … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A building on the campus of Illumina’s global headquarters is shown in San Diego, California, on September 1, 2021. Mike Blake | Reuters Illumina on Tuesday disclosed plans to cut costs to improve the dwindling margins of the DNA sequencing company. The plans aim to reduce … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Abbott manufacturing facility in Sturgis, Michigan on May 13, 2022. Jeff Kowalsky | AFP | Getty Images Company shares Abbott Laboratories fell on Wednesday after the company’s earnings and revenue beat Wall Street expectations, despite a dramatic slowdown in sales of its Covid-19 tests. The medical … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Janssen Johnson & Johnson vaccine against COVID-19. Allen J. Schaben | Los Angeles Times | Getty Images International sales of the covid vaccine helped spark the spark Johnson & JohnsonRevenue and earnings were higher on Tuesday, but the company said it does not expect any sales … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Before the bell on Tuesday, Johnson & Johnson ( JNJ ) reported a strong first quarter, with sales up more than 5.5% and profit up year-over-year. Shares of the Dow component and Club holding should not lose 2.5% on such results. J&J’s first-quarter sales of $24.75 … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Dow Falls, Profits in Focus J & J Declines Missed Starbucks Undervalued? 1. Dow falls with earnings taking center stage Stocks … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Artur Widak | NurPhoto | Getty Images Johnson & Johnson on Tuesday reported adjusted earnings and revenue that beat Wall Street expectations and raised its full-year forecast. J&J, whose financial results are considered leaders for many healthcare companies, said its first-quarter sales rose 5.6% compared with … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A man walks near a Walgreens pharmacy on March 9, 2023 in New York City. Leonardo Munoz | Corbis News | Getty Images Walgreens Boots Alliance said on Tuesday that its quarterly profit fell by more than 20%, helped by sharply lower volumes of covid vaccine … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Life sciences and medical diagnostics company Danaher (DHR) reported better-than-expected fourth-quarter earnings and revenue. Revenue rose nearly 10% on an underlying basis to $8.37 billion, well above estimates of $7.9 billion, according to Refinitiv. Adjusted earnings rose 6.7% to $2.87 per share, beating the consensus estimate … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The year ahead is a crucial one for Eli Lilly ( LLY ) as the pharmaceutical giant looks to advance the drugs in its star lineup. Executives detailed reasons for optimism at a major industry meeting this week. “It’s another unprecedented year ahead for Lilly,” Chief … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE While Wall Street tried to hang on to recent gains on Tuesday, we got some positive news on two Club holdings that are seeing big moves to the upside: Danaher ( DHR ) and Constellation Brands ( STZ ). DHR 1Y mountain Danaher’s 1-year stock performance … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In this photo, a silhouette of a man holding a medical syringe and vial is shown in front of the Novavax logo on the screen. Cezary Kowalski Lightrocket | Getty Images Novavax posted an unexpected loss on Thursday but beat Wall Street’s third-quarter revenue expectations. The … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Four of our club holdings — Costco Wholesale ( COST ), Amazon ( AMZN ), Humana ( HUM ) and Bausch Health ( BHC ) — were in the news Thursday. Here’s how we feel about the turn of events. Costco News: Costco reported sales for … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Club holding company Humana ( HUM ) reported a mixed but solid third quarter ahead of Wednesday’s open. Early optimism about 2023 also supported our bullish view on the health insurance company’s stock. Revenue rose 9% year-over-year to $22.75 billion, slightly missing estimates of $22.76 billion, … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We never like to sell on a bad day. But after a dubious quarter, we decided to exit. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Analysts at Deutsche Bank took Humana to a buy rating, citing its “leadership in Medicare Advantage.” . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It was a solid quarter for Johnson & Johnson, but the strong dollar is and will remain a headwind for the foreseeable future. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE CVS Pharmacy is prominently located in Manhattan, New York City, New York. Shannon Stapleton | Reuters CVS said Wednesday that it plans to acquire or take a stake in a primary care company by the end of the year as competition intensifies. Amazon and Walgreens. CEO … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE People walk past CVS Pharmacy in Manhattan, New York. Shannon Stapleton | Reuters CVS Health raised its profit outlook for the year on Wednesday after beating Wall Street expectations for the fiscal second quarter. The healthcare company said it now expects full-year adjusted earnings per share … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE AbbVie hasn’t had quite the quarter, but Friday’s selloff is a bit puzzling. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE There may also be some disappointment that the guidance going forward was not stronger. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Traders work at the New York Stock Exchange (NYSE) on January 18, 2022 in New York City. The Dow Jones Industrial Average fell nearly 500 points in morning trading as investors weighed quarterly earnings and other economic news in a shortened trading week. Spencer Platt | … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The CVS Pharmacy store is visible in Manhattan County, New York City. Shannon Stapleton Reuters CVS health on Wednesday surpassed Wall Street’s expectations for first-quarter profits and raised its guidelines for the year as it saw demand for Covid tests at home, recipes and more. The … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE China’s smartphone market could decline in the second quarter as the country experiences a resurgence in covid cases, analysts say. But Apple could do well, analysts said, as it continues to attract users to the top market. Publishing of the future Publishing of the future Getty … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The response of donanemab’s accelerated approval is seen only as speed. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Janssen Johnson & Johnson vaccine against COVID-19. Allen J. Schaben Los Angeles Times | Getty Images Johnson & Johnson announced on Tuesday that its Covid vaccine will generate $ 3 billion to $ 3.5 billion in sales after 2022, after publishing a mixed report for the … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The person enters the Walgreens store in San Francisco, California, USA, on Tuesday, April 13, 2021. David Paul Morris Bloomberg | Getty Images Walgreens Boots Alliance on Thursday, it exceeded analysts’ expectations for the first quarter of the budget and raised its forecast for the year … Read more
Delnice Penn National Gaming Inc. PENN, -21.08% on Thursday then fell by more than 20%. large loss of profit in the third quarter and allegations of sexual abuse against the founder of Barstool Sports. According to Dow Jones Market Data, the fall wiped out more than $ 2.5 billion of Penn National’s market capitalization, the … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Modern shares fell more than 16% on Thursday after lowering its forecast for Covid-19 vaccine sales for the year and missing earnings and revenue expectations for the third quarter. The company said that some doses for supply this year were postponed to early 2022 due to … Read more
MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The customer walks towards the entrance to the CVS Health Corp. store. in downtown Los Angeles, California, USA, on Friday, October 27, 2017. Christopher Lee | Bloomberg | Getty Images CVS health on Wednesday beat third-quarter profit expectations and improved its outlook for the year as … Read more